Revisiting Tuberculosis (TB) Diagnosis: The Prospect Of Urine Lipoarabinomannan (Lam) Assay As A Diagnostic Tool In People Living With HIV

BackgroundTuberculosis (TB), since its discovery has become a global health burden, continuously spreading across the nations of the earth with increased mortality. Its effect on human immunodeficiency virus (HIV) progression and immune cell deterioration cannot be overlooked. The widespread use of traditional and molecular TB diagnostic methods has been hindered by several factors. Nonetheless, the development of a rapid, sensitive, timely, non-invasive diagnostic protocol could revolutionize the diagnostic era and halt the spread of this infectious agent. It could also help in the early diagnosis of the infection in poorly developed areas. The detection efficacy of urine lipoarabinomannan assay as a prospect in tuberculosis diagnosis in HIV-positive patients was assessed in this study. Urine samples were collected into a wide- mouthed universal container from HIV-positive patients with signs and symptom of tuberculosis and HIV advanced disease. Alere Determine urine lateral flow - LAM test was used for the detection of LAM antigen in urine samples of HIV-positive patients. The CD4 count of the HIV- positive patients was also documented. ResultsA total of 85 HIV-positive subjects were included in the analysis based on the inclusion criteria. Urinary LAM was reactive in 29 (34.1%) of 85 HIV-positive patients and non-reactive in 56 (69.1%). The majority of the participants had a CD4+ count < 200 cells/{micro}L 60 (70.6%) while others had CD4+ count [&ge;] to 200 cells/{micro}L 25 (29.4%). There was no statistically significant difference between CD4 count and LAM positivity. Most of the affected age groups in the study were 31-45 years, and females had preponderance in comparison to male subjects. ConclusionsThe use of urinary LAM in HIV-positive patients is a helpful tool for TB screening. It also has a promising ability for early TB diagnosis in the study group and other TB-associated disease conditions in resource-deprived settings. For the general populace, further research is required to certify its sensitivity and specificity.